2891 |
URGENDOL INJECTION |
TRAMADOL HYDROCHLORIDE BP 50 MG |
SOLUTION FOR INJECTION |
AMPOULES |
MANAGEMENT OF MODERATE TO SEVERE ACUTE OR CHRONIC PAIN, AND IN PAINFUL DIAGNOSTIC OR SURGICAL PROCEDURES |
NULL |
VIMPEX (LAO) CO.,LTD |
WIN-MEDICARE PRIVATE LIMITED |
INDIA |
CERTIFICATE RELEASED |
12 I 5025/20 |
08-APR-2024 |
07-APR-2027 |
View |
2892 |
URGENDOL P |
PARACETAMOL BP 325 MG, TRAMADOL HYDROCHLORIDE BP 37.5 MG |
TABLET |
BLISTERPACK |
MANAGEMENT OF ACUTE PAIN |
NULL |
VIMPEX (LAO) CO.,LTD |
WIN-MEDICARE PRIVATE LIMITED |
INDIA |
CERTIFICATE RELEASED |
12 I 5024/20 |
08-APR-2024 |
07-APR-2027 |
View |
2893 |
VALCONTIN 200 |
VALPROIC ACID USP 58 MG, SODIUM VALPROATE BP 133.50 MG |
FILM COATED TABLET |
ALU-ALU |
TREATMENT OF GENERALIZED SEIZURES, NOTABLY TONIC-CLONIC, ABSENCE AND MYOCLONIC SEIZURES AND ALSO FOR PARTIAL SEIZURE (SIMPLE AND COMPLEX) |
NULL |
VIMPEX (LAO) CO.,LTD |
MODI-MUNDIPHARMA PRIVATE LTD |
INDIA |
CERTIFICATE RELEASED |
12 I 5360/22 |
30-DEC-2022 |
29-DEC-2025 |
View |
2894 |
VALCONTIN 500 |
VALPROIC ACID USP 145 MG, SODIUM VALPROATE BP 333 MG |
FILM COATED TABLET |
ALU-ALU |
TREATMENT OF GENERALIZED SEIZURES, NOTABLY TONIC-CLONIC, ABSENCE AND MYOCLONIC SEIZURES AND ALSO FOR PARTIAL SEIZURE (SIMPLE AND COMPLEX) |
NULL |
VIMPEX (LAO) CO.,LTD |
MODI-MUNDIPHARMA PRIVATE LTD |
INDIA |
CERTIFICATE RELEASED |
12 I 5361/22 |
30-DEC-2022 |
29-DEC-2025 |
View |
2895 |
VIRQ |
ACYCLOVIR SODIUM 250 MG |
POWDER FOR SOLUTION FOR INJECTION |
VIAL |
PREVENTION AND TREATMENT OF HERPES SIMPLEX VIRUS INFECTIONS, INITIAL AND RECURRENT VARICELLA -ZOSTER VIRUS INFECTIONS, SEVERE INITIAL GENITAL HERPES INFECTIONS AND ENCEPHALITIS DUE TO HERPES SIMPLEX VIRUS. |
NULL |
VIMPEX (LAO) CO.,LTD |
WILSHIRE LABORATORIES(PVT) LTD |
PAKISTAN |
CERTIFICATE RELEASED |
11 I 4626/18 |
26-SEP-2022 |
25-SEP-2025 |
View |
2896 |
VISCOF SYRUP |
EACH 5 ML CONTAINS: AMBROXOL HYDROCHLORIDE BP 30 MG, GUAIFENESIN BP 50 MG, RACEMENTHOL BP 1 MG |
SYRUP |
BOTTLE |
IS MEDICATION ACT AS MUCOLYTIC AGENT, PRESCRIBED FOR VARIOUS RESPIRATORY DISEASES SUCH AS EMPHYSEMA WITH BRONCHITIS PNEUMOCONIOSIS, CHRONIC INFLAMMATORY PULMONARY CONDITIONS, TRACHEOBRONCHITIS (RESPIRATORY TRACT INFLAMMATION), BRONCHIECTASIS, BRONCHITIS WITH BRONCHOSPASM ASTHMA AND SMOKERS COUGH |
NULL |
VIMPEX (LAO) CO.,LTD |
SAI MIRRA INNOPHARM PVT.LTD |
INDIA |
CERTIFICATE RELEASED |
01 I 5387/23 |
23-Jan-2023 |
22-Jan-2026 |
View |
2897 |
VISCOF-S SYRUP |
EACH 5 ML CONTAINS: SALBUTAMOL SULFATE BP EQ.TO SALBUTAMOL 2 MG, AMBROXOL HYDROCHLORIDE BP 30 MG, GUAIFENESIN BP 50 MG, RACEMENTHOL BP 1 MG. |
SYRUP |
BOTTLE |
IS MEDICATION ACT AS MUCOLYTIC AGENT, PRESCRIBED FOR VARIOUS RESPIRATORY DISEASES SUCH AS EMPHYSEMA WITH BRONCHITIS PNEUMOCONIOSIS, CHRONIC INFLAMMATORY PULMONARY CONDITIONS, TRACHEOBRONCHITIS (RESPIRATORY TRACT INFLAMMATION), BRONCHIECTASIS, BRONCHITIS WITH BRONCHOSPASM ASTHMA AND SMOKERS COUGH |
NULL |
VIMPEX (LAO) CO.,LTD |
SAI MIRRA INNOPHARM PVT.LTD |
INDIA |
CERTIFICATE RELEASED |
01 I 5386/23 |
23-Jan-2023 |
22-Jan-2026 |
View |
2898 |
VOLIGEL |
EACH 100G CONTAINS DICLOFENAC DIETHYLAMINE BP 1 160 MG EQ.TO DICLOFENAC SODIUM 1G |
GEL |
Tube |
FOR THE LOCAL SYMPTOMATIC RELIEF OF PAIN AND INFLAMMATION IN: TRAUMA OF THE TENDONS, LIGAMENT, MUSCLE AND JOINTS AND LOCALIZED FORMS OF SOFT TISSUE RHEUMATISM |
NULL |
VIMPEX (LAO) CO.,LTD |
BEXIMCO PHARMACEUTICALS LTD |
BANGLADESH |
CERTIFICATE RELEASED |
06 I 4738/19 |
08-JAN-2024 |
07-JAN-2027 |
View |
2899 |
VOMILUX |
DOMPERIDONE BP 1 MG/ML |
SUSPENSION |
BOTTLE |
FOR THE RELIEF OF SYMPTOMS OF NAUSEA AND VOMITING |
NULL |
VIMPEX (LAO) CO.,LTD |
ATCO LABORATORIES LIMITED |
PAKISTAN |
CERTIFICATE RELEASED |
12 I 5362/22 |
30-DEC-2022 |
29-DEC-2025 |
View |
2900 |
XINC B |
EACH 100 ML CONTAINS: THIAMINE HYDROCHLORIDE USP 0.100G, RIBOFLAVIN 0.040G, PYRIDOXINE HYDROCHLORIDE USP 0.040G, NICOTINAMIDE USP 0.400G, ZINC SULFATE MONOHYDRATE USP 0.549 G EQ.TO ELEMENTAL ZINC 0.200 G |
SYRUP |
BOTTLE |
TREATMENT AND PREVENTION OF ZINC AND VITAMIN B DIFICIENCIES |
NULL |
VIMPEX (LAO) CO.,LTD |
ESKAYEF PHARMACEUTICALS LIMITED |
BANGLADESH |
CERTIFICATE RELEASED |
07 I 4525/18 |
07-JUL-2025 |
06-JUL-2030 |
View |